−0.89USD
−42.21 MUSD
16.23 M
About Pulse Biosciences, Inc
Sector
Industry
CEO
Kevin P. Danahy
Website
Headquarters
Hayward
Employees (FY)
56
Founded
2014
ISIN
US74587B1017
FIGI
BBG00BRBHVD0
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PLSE is 7.36 USD — it has decreased by 1.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulse Biosciences, Inc stocks are traded under the ticker PLSE.
Pulse Biosciences, Inc is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
PLSE stock is 3.51% volatile and has beta coefficient of 1.23. Check out the list of the most volatile stocks — is Pulse Biosciences, Inc there?
PLSE earnings for the last quarter are −0.15 USD whereas the estimation was −0.24 USD which accounts for 36.73% surprise. Estimated earnings for the next quarter are −0.24 USD. See more details about Pulse Biosciences, Inc earnings.
Pulse Biosciences, Inc revenue for the last quarter amounts to 265.00 K USD despite the estimated figure of 439.67 K USD. In the next quarter revenue is expected to reach 200.00 K USD.
Yes, you can track Pulse Biosciences, Inc financials in yearly and quarterly reports right on TradingView.
PLSE stock has fallen by 0.81% compared to the previous week, the month change is a 23.41% fall, over the last year Pulse Biosciences, Inc has showed a 25.60% increase.
PLSE net income for the last quarter is −11.93 M USD, while the quarter before that showed −10.57 M USD of net income which accounts for −12.94% change. Track more Pulse Biosciences, Inc financial stats to get the full picture.
Today Pulse Biosciences, Inc has the market capitalization of 412.53 M, it has decreased by 2.21% over the last week.
No, PLSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PLSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulse Biosciences, Inc stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 56.00 employees. See our rating of the largest employees — is Pulse Biosciences, Inc on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pulse Biosciences, Inc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pulse Biosciences, Inc stock shows the sell signal. See more of Pulse Biosciences, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.